TRACY WINKELMANN: Open Payments
NPI 1699317875 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 41 payments from 15 companies in 2025. Trend: 2023 $235 · 2024 $621 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $214 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Abbott Laboratories | 1 | $21 |
Products named: VRAYLAR, UBRELVY, JARDIANCE, AIRSUPRA, Symbravo, Wegovy, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
